# US 2015/0176059 A1 · Oligonucleotide inhibitor of dna polymerases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0176059 A1
- Document ID: US20150176059A1
- Status: Published application
- Kind: A1
- Application number: 14/562,351
- Filed: 2014-12-05
- Published: 2015-06-25
- Earliest claimed: 2013-12-20
- Assignees: Roche Molecular Systems, Inc.
- Applicants: Roche Molecular Systems, Inc.
- Inventors: Ellen Fiss; Joseph San Filippo
- Web page: https://patentgrep.com/patent/US20150176059A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- C12N 9/99: Enzyme inactivation by chemical treatment
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/115: Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}
- C12N 2310/16: Aptamers
- C12N 2310/531: Stem-loop; Hairpin
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention comprises a reversible oligonucleotide inhibitor of nucleic acid polymerases. Methods of designing said inhibitors and using said inhibitors in amplification and detection of nucleic acid, particularly detection of RNA by RT-PCR are also disclosed.

## Claims

### Claim 1

A reversible inhibitor of nucleic acid polymerases comprising a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 2 (depends on 1)

The reversible inhibitor of claim 1 wherein said double-stranded secondary structure is stable under ambient temperature in a PCR mixture.

### Claim 3 (depends on 1)

The reversible inhibitor of claim 1 comprising SEQ ID NO:1 wherein one or more thymine bases are replaced with a uracil base.

### Claim 4 (depends on 1)

The reversible inhibitor of claim 1 selected from SEQ ID NOs: 2-4.

### Claim 5

A method of designing a reversible inhibitor of nucleic acid polymerases comprising designing a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 6 (depends on 5)

The method of claim 5 wherein in the DNA oligonucleotide is selected from a mixture of oligonucleotides using systematic evolution of ligands by exponential enrichment (SELEX).

### Claim 7

A method of reversibly inhibiting a nucleic acid polymerase in a reaction mixture comprising contacting the mixture with a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 8 (depends on 7)

The method of claim 7, further comprising contacting the mixture with a uracil-N-glycosylase.

### Claim 9 (depends on 8)

The method of claim 8, wherein the contacting takes place in the temperature range of 40-65° C.

### Claim 10 (depends on 7)

The method of claim 7, further comprising contacting the sample with a polyamine.

### Claim 11 (depends on 10)

The method of claim 10, wherein the polyamine is selected from spermidine, spermine and trimethylenediamine.

### Claim 12

A method of amplifying a target nucleic acid comprising prior to amplification, contacting a reaction mixture containing the target nucleic acid with a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 13 (depends on 12)

The method of claim 12, further comprising prior to amplification, contacting the sample with a uracil-N-glycosylase.

### Claim 14 (depends on 12)

The method of claim 12, further comprising contacting the sample with a polyamine.

### Claim 15 (depends on 14)

The method of claim 14, wherein the polyamine is selected from spermidine, spermine and trimethylenediamine.

### Claim 16

A kit for amplifying a target nucleic acid containing a reversible inhibitor of a nucleic acid polymerase comprising a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 17 (depends on 16)

The kit of claim 16, further comprising uracil-N-glycosylase.

### Claim 18 (depends on 16)

The kit of claim 16, further comprising a polyamine, optionally selected from spermidine, spermine and trimethylenediamine.

### Claim 19

A reaction mixture for amplifying a target nucleic acid containing a reversible inhibitor of a nucleic acid polymerase comprising a single-stranded DNA oligonucleotide having one or more regions of double-stranded secondary structure, wherein at least one of said regions comprises at least one uracil base.

### Claim 20 (depends on 19)

The reaction mixture of claim 19, further comprising uracil-N-glycosylase.

### Claim 21 (depends on 20)

The reaction mixture of claim 20, further comprising a polyamine, optionally selected from spermidine, spermine and trimethylenediamine.
